100 related articles for article (PubMed ID: 9933852)
41. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
[TBL] [Abstract][Full Text] [Related]
42. Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management.
Van Wyck DB
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):21-4. PubMed ID: 2669082
[TBL] [Abstract][Full Text] [Related]
43. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation.
Goodnough LT; Verbrugge D; Marcus RE; Goldberg V
J Am Coll Surg; 1994 Aug; 179(2):171-6. PubMed ID: 8044386
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA
Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
[TBL] [Abstract][Full Text] [Related]
45. Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study.
Kosmadakis N; Messaris E; Maris A; Katsaragakis S; Leandros E; Konstadoulakis MM; Androulakis G
Ann Surg; 2003 Mar; 237(3):417-21. PubMed ID: 12616127
[TBL] [Abstract][Full Text] [Related]
46. Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: reduced need for blood transfusions in patients undergoing colorectal surgery--prospective double-blind placebo-controlled study.
Qvist N; Boesby S; Wolff B; Hansen CP
World J Surg; 1999 Jan; 23(1):30-5. PubMed ID: 9841760
[TBL] [Abstract][Full Text] [Related]
47. Bioavailability of iron in hemodialysis patients treated with erythropoietin: evidence for the inhibitory role of aluminum.
Donnelly SM; Ali MA; Churchill DN
Am J Kidney Dis; 1990 Nov; 16(5):447-51. PubMed ID: 2239935
[TBL] [Abstract][Full Text] [Related]
48. Uremic inhibitors of erythropoiesis: a study during treatment with recombinant human erythropoietin.
Brunati C; Cappellini MD; De Feo T; Guastoni C; Ballerini L; Busnach G; Civati G; Fiorelli G; Minetti L
Am J Nephrol; 1992; 12(1-2):9-13. PubMed ID: 1415372
[TBL] [Abstract][Full Text] [Related]
49. Preoperative administration of recombinant human erythropoietin in patients undergoing gynecologic surgery.
Sesti F; Ticconi C; Bonifacio S; Piccione E
Gynecol Obstet Invest; 2002; 54(1):1-5. PubMed ID: 12297709
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study.
Liu S; Ren J; Hong Z; Yan D; Gu G; Han G; Wang G; Ren H; Chen J; Li J
Nutr Clin Pract; 2013 Feb; 28(1):120-7. PubMed ID: 23064018
[TBL] [Abstract][Full Text] [Related]
51. Recombinant human erythropoietin for autologous blood donation: effects on perioperative red-blood-cell and serum erythropoietin production.
Tasaki T; Ohto H; Hashimoto C; Abe R; Saitoh A; Kikuchi S
Lancet; 1992 Mar; 339(8796):773-5. PubMed ID: 1347803
[TBL] [Abstract][Full Text] [Related]
52. Treatment of erythropoietin-resistant anaemia with desferrioxamine in patients on haemofiltration.
Goch J; Birgegård G; Danielson BG; Wikström B
Eur J Haematol; 1995 Aug; 55(2):73-7. PubMed ID: 7628592
[TBL] [Abstract][Full Text] [Related]
53. Potential for treatment of anaemia of prematurity with recombinant human erythropoietin: preliminary results.
Phibbs RH; Shannon KM; Mentzer WC
Acta Haematol; 1992; 87 Suppl 1():28-33. PubMed ID: 1574965
[TBL] [Abstract][Full Text] [Related]
54. Erythropoietin increases hemoglobin in cancer patients during radiation therapy.
Lavey RS; Dempsey WH
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1147-52. PubMed ID: 8262840
[TBL] [Abstract][Full Text] [Related]
55. [A therapeutical approach by administering reduced glutathione to patients with uremic anemia].
Xia N; Qu S
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):300-2. PubMed ID: 12600115
[TBL] [Abstract][Full Text] [Related]
56. Perisurgical erythropoietin application in anemic patients with colorectal cancer: A double-blind randomized study.
Heiss MM; Tarabichi A; Delanoff C; Allgayer H; Jauch KW; Hernandez-Richter T; Mempel W; Beck KG; Schildberg FW; Messmer K
Surgery; 1996 May; 119(5):523-7. PubMed ID: 8619207
[TBL] [Abstract][Full Text] [Related]
57. [Pharmacodynamics and therapeutic usage of recombinant human erythropoietin (SNB-5001) in animal models].
Masunaga H; Takahira R; Hirabayashi M; Sawai T
Nihon Yakurigaku Zasshi; 1992 Apr; 99(4):213-29. PubMed ID: 1607131
[TBL] [Abstract][Full Text] [Related]
58. Effective administration of erythropoietin for renal anemia.
Masunaga H; Ueda M; Sawai T; Kawanishi G
Nihon Juigaku Zasshi; 1989 Aug; 51(4):783-8. PubMed ID: 2585932
[TBL] [Abstract][Full Text] [Related]
59. Does recombinant human erythropoietin accelerate erythropoiesis for predonation before cardiac surgery?
Hayashi J; Shinonaga M; Nakazawa S; Miyamura H; Eguchi S; Shinada S
Jpn Circ J; 1993 Jun; 57(6):475-9. PubMed ID: 8340993
[TBL] [Abstract][Full Text] [Related]
60. Beyond erythropoiesis: novel applications for recombinant human erythropoietin.
Cerami A
Semin Hematol; 2001 Jul; 38(3 Suppl 7):33-9. PubMed ID: 11523026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
